Looking to publish in American Journal of Cardiovascular Drugs? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.
Existing customer loginAmerican Journal of Cardiovascular Drugs promotes rational therapy within cardiology and covers all aspects of the treatment of cardiovascular disorders, with particular emphasis on the place in therapy of newer and established agents. The journal publishes reviews and original clinical research on pharmacology, efficacy, adverse effects, newly developed drugs and drug classes, therapeutic implications of research into cardiovascular disease aetiology, and practical management of specific clinical situations.
Looking to publish in American Journal of Cardiovascular Drugs? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.
Existing customer loginSubmission Instructions
American Journal of Cardiovascular Drugs accepts the following article types. Click on an article type to view submission instructions.
Review Article
Therapy In Practice Reviews
Systematic Review
Original Research Articles
Comprehensive Narrative Reviews
Letter To The Editor
Adis Drug Reviews
Recent Publications
Temporal Trends and Predictors of P2Y12 Inhibitor Selection and Switching Following Percutaneous Coronary Intervention in Acute Coronary Syndrome Patients
Young Eun Shin, Arun Kumar, Anne Metzger, Patricia Wigle, Jeff Jianfei Guo, Ana L. Hincapie
Beta-Blockers for the Treatment of Arrhythmias: Which Drug for Which Arrhythmia? A State-of-the-Art Narrative Review
Lucian Muresan, Gabriel Cismaru, Stefan Lucian Popa, Radu Rosu, Gabriel Gusetu, Mihai Puiu, Razvan Olimpiu Mada, Crina Muresan, Ronan Le Bouar, Serban Schiau, Charline Daval, Jacques Levy, Raphael Pedro Martins
SGLT2 Inhibitors in Cardiovascular-Kidney-Metabolic Syndrome: Drugs Unifying Heart, Kidney, and Metabolism Pharmacotherapy
Valentina Okhovat, Kamela Lybeshari, Luigi X. Cubeddu, Genevieve Hale
Lipoprotein(a): Cardiovascular Risk and Emerging Targeted Therapies
José Pablo Miramontes González
Vutrisiran in Transthyretin Amyloidosis: A Narrative Review
Kamela Lybeshari, Huy Pham, Genevieve Hale
Frequently asked questions
How long does it take to publish?
Manuscripts undergo initial editorial appraisal, external peer review, copy editing, proof review, and online first publication after receipt of corrected proofs.
Reformat to American Journal of Cardiovascular Drugs using Livewrite PremiumIs a cover letter required?
A covering letter is required at submission and should state the article type, why the paper is important, what the review or study covers or found, why it would interest the journal’s readership, and any other pertinent information. Previous editorial or referee comments from prior submissions should be provided when applicable.
Reformat to American Journal of Cardiovascular Drugs using Livewrite PremiumWhat are the publication costs?
Open access APC is £3090.00 GBP / $4990.00 USD / €3990.00 EUR. Subscription publication has no APC. Open access or subscription is chosen after acceptance.
Reformat to American Journal of Cardiovascular Drugs using Livewrite Premium